ECP
SRTA

Empyrean Capital Partners’s Strata Critical Medical Inc SRTA Stock Holding History

Empyrean Capital Partners’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-500,000
Closed -$1.47M – 74
2024
Q3 		$1.47M Buy
+500,000
New +$1.59M 0.06% 62

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Empyrean Capital Partners's SRTA Position: Q4 2024 in Review

Empyrean Capital Partners sold out of Strata Critical Medical Inc (SRTA) in Q4 2024, closing a stake of 500,000 shares — an estimated $1.47M sold.

Empyrean Capital Partners first reported a position in SRTA in Q3 2024 and held it in 1 quarter. The position peaked at $1.47M in Q3 2024. 122 funds tracked by Wall St. Rank hold SRTA as of Q4 2024.

  • Empyrean Capital Partners reported no remaining Strata Critical Medical Inc position as of Q4 2024 after selling out during the quarter.
  • Empyrean Capital Partners sold 500,000 Strata Critical Medical Inc shares in Q4 2024, an estimated $1.47M.
  • Empyrean Capital Partners first reported a position in Strata Critical Medical Inc in Q3 2024 and held it in 1 quarter.
  • Empyrean Capital Partners's Strata Critical Medical Inc position peaked at $1.47M in Q3 2024.
  • 122 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2024.

Based on Empyrean Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.